Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Highly active antiretroviral therapy does not affect mitochondrial beta-oxidation of fatty acids: an in vitro study in fibroblasts.

Butt YM, Kamrudin SA, Rakheja D.

Pediatr Dev Pathol. 2008 Jan-Feb;11(1):35-8. doi: 10.2350/06-11-0186.1.

PMID:
18240871
[PubMed - indexed for MEDLINE]
2.

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Tyni T, Pihko H.

Acta Paediatr. 1999 Mar;88(3):237-45. Review.

PMID:
10229030
[PubMed - indexed for MEDLINE]
3.

Liver disease in pregnancy and fetal fatty acid oxidation defects.

Ibdah JA, Yang Z, Bennett MJ.

Mol Genet Metab. 2000 Sep-Oct;71(1-2):182-9. Review.

PMID:
11001809
[PubMed - indexed for MEDLINE]
4.

Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?

Thorne C, Newell ML.

Drug Saf. 2007;30(3):203-13. Review.

PMID:
17343429
[PubMed - indexed for MEDLINE]
5.

Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications.

Strauss AW, Bennett MJ, Rinaldo P, Sims HF, O'Brien LK, Zhao Y, Gibson B, Ibdah J.

Semin Perinatol. 1999 Apr;23(2):100-12. Review.

PMID:
10331463
[PubMed - indexed for MEDLINE]
6.

Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.

Spiekerkoetter U.

J Inherit Metab Dis. 2010 Oct;33(5):527-32. doi: 10.1007/s10545-010-9090-x. Epub 2010 May 7. Review.

PMID:
20449660
[PubMed - indexed for MEDLINE]
7.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
8.

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian.

PMID:
15305694
[PubMed - indexed for MEDLINE]
9.

Treating HIV during pregnancy: an update on safety issues.

Watts DH.

Drug Saf. 2006;29(6):467-90. Review.

PMID:
16752931
[PubMed - indexed for MEDLINE]
10.

[Mitochondrial 3-hydroxyacyl-CoA dehydrogenase (SCHAD, LCHAD)].

Yamaguchi S.

Nihon Rinsho. 2002 Apr;60 Suppl 4:101-4. Review. Japanese. No abstract available.

PMID:
12013827
[PubMed - indexed for MEDLINE]
11.

Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management.

Shekhawat PS, Matern D, Strauss AW.

Pediatr Res. 2005 May;57(5 Pt 2):78R-86R. Epub 2005 Apr 6. Review.

PMID:
15817498
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Recent developments in the investigation of inherited metabolic disorders using cultured human cells.

Roe CR, Roe DS.

Mol Genet Metab. 1999 Oct;68(2):243-57. Review.

PMID:
10527676
[PubMed - indexed for MEDLINE]
13.

Absence of the G1528C (E474Q) mutation in the alpha-subunit of the mitochondrial trifunctional protein in women with acute fatty liver of pregnancy.

Maitra A, Domiati-Saad R, Yost N, Cunningham G, Rogers BB, Bennett MJ.

Pediatr Res. 2002 May;51(5):658-61. Review.

PMID:
11978893
[PubMed - indexed for MEDLINE]
14.

Compromised fatty acid oxidation in mitochondrial disorders.

Hagenfeldt L.

J Inherit Metab Dis. 1998 Aug;21(5):613-7. Review.

PMID:
9728341
[PubMed - indexed for MEDLINE]
15.

Drug interactions of new antiretroviral drugs.

Serrano López de Las Hazas JI.

Farm Hosp. 2011 Jan-Feb;35(1):36-43. doi: 10.1016/j.farma.2010.01.018. Epub 2011 Jan 3. Review. English, Spanish.

PMID:
21208819
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk